Non-small cell lung cancer (NSCLC) is a serious disease and has a high recurrence rate after the surgery. Recently, many machine learning methods have been proposed for recurrence prediction. The methods using gene data have high prediction accuracy but require high cost. Although the radiomics signatures using only CT image are not expensive, its accuracy is relatively low. In this paper, we propose a genotype-guided radiomics method (GGR) for obtaining high prediction accuracy with low cost. We used a public radiogenomics dataset of NSCLC, which includes CT images and gene data. The proposed method is a two-step method, which consists of two models. The first model is a gene estimation model, which is used to estimate the gene expression from radiomics features and deep features extracted from computer tomography (CT) image. The second model is used to predict the recurrence using the estimated gene expression data. The proposed GGR method designed based on hybrid features which is combination of handcrafted-based and deep learning-based. The experiments demonstrated that the prediction accuracy can be improved significantly from 78.61% (existing radiomics method) and 79.14% (deep learning method) to 83.28% by the proposed GGR.
Discovery Radiomics via Evolutionary Deep Radiomic Sequencer Discovery for Pathologically-Proven Lung Cancer Detection
Vision and Image Processing Research Group, University of Waterloo(滑铁卢大学视觉与图像处理研究组);Department of Medical Imaging, University of Toronto and Sunnybrook Research Institute(多伦多大学医学影像系与森尼布鲁克研究所)
Radiomic Feature Selection Using Gradient Loss of Deep Neural Network for Lung Cancer Stage Detection
Department of Software Engineering, Bahria University(巴尔ia大学软件工程系);Global College of Engineering and Technology(全球工程与技术学院);Software Engineering & Business Incubation Center, Bahria University(软件工程与企业孵化中心,巴尔ia大学)
Foundation Models vs. Radiomics for Lung Computed Tomography: A Benchmark of Feature Extractors, Classification Heads, and Segmentation Choices
Division AI4Health, Carl von Ossietzky Universität Oldenburg(奥尔登堡卡尔·冯·奥西茨基大学AI4Health部门);University Institute for Diagnostic and Interventional Radiology, Klinikum Oldenburg AöR(奥尔登堡医院大学诊断与介入放射学研究所)
Application of the nnU-Net for automatic segmentation of lung lesion on CT images, and implication on radiomic models
IEO European Institute of Oncology IRCCS(IEO欧洲肿瘤研究所IRCCS);Technical University of Munich(慕尼黑工业大学);University of Milan(米兰大学);Istituto Imaging della Svizzera Italiana (IIMSI)(瑞士意大利语区成像研究所(IIMSI));Università della Svizzera italiana(瑞士意大利语区大学);Bern University Hospital(伯尔尼大学医院);University of Bern(伯尔尼大学)
Magnetic resonance delta radiomics to track radiation response in lung tumors receiving stereotactic MRI-guided radiotherapy
Mass General Brigham(麻省总医院布里格姆医疗系统);Harvard Medical School(哈佛医学院);Dana-Farber Cancer Institute(丹娜-法伯癌症研究所);Harvard T.H. Chan School of Public Health(哈佛大学陈曾熙公共卫生学院);Maastricht University(马斯特里赫特大学)
Adaptive Fusion of Radiomics and Deep Features for Lung Adenocarcinoma Subtype Recognition
Renmin University of China(中国人民大学);Capital Medical University(首都医科大学);Beijing Chao-Yang Hospital(北京朝阳医院);Beijing Institute of Respiratory Medicine(北京呼吸疾病研究所)
Incremental Value and Interpretability of Radiomics Features of Both Lung and Epicardial Adipose Tissue for Detecting the Severity of COVID-19 Infection
School of Computer and Communication Engineering, Zhengzhou University of Light Industry(郑州轻工业大学计算机与通信工程学院);Universidade Federal Fluminense(弗鲁米嫩塞联邦大学);DASA Complexo Hospitalar de Niterói(达萨尼泰罗伊医院综合体);Michigan Technological University(密歇根理工大学);Zhongshan Hospital, Fudan University(复旦大学附属中山医院);Shanghai Institute of Cardiovascular Diseases(上海市心血管病研究所);National Clinical Research Center for Interventional Medicine(国家介入医学临床研究中心);Center for Biocomputing and Digital Health, Institute of Computing and Cybersystems, and Health Research Institute, Michigan Technological University(密歇根理工大学生物计算与数字健康中心、计算与网络系统研究所及健康研究所)
Training Set Augmentation and Biology-Aware Harmonization Improve Radiomic Models for Lung Cancer Prediction in Indeterminate Nodules
Department of Radiation Oncology, University of Virginia School of Medicine(弗吉尼亚大学医学院放射肿瘤学系);Department of Physics, University of Virginia(弗吉尼亚大学物理系);Department of Physics, Massachusetts Institute of Technology(麻省理工学院物理系);Department of Biomedical Engineering, Northwestern University(西北大学生物医学工程系);Department of Radiation Oncology, University of Virginia(弗吉尼亚大学放射肿瘤学系);Old Dominion University(旧 Dominion 大学)
Pretty Good Measurement for Radiomics: A Quantum-Inspired Multi-Class Classifier for Lung Cancer Subtyping and Prostate Cancer Risk Stratification
Università degli Studi di Cagliari(卡利亚里大学);Institute of Bioimaging and Complex Biological Systems - National Research Council (IBSBC - CNR)(生物成像与复杂生物系统研究所 - 国家研究委员会);National Laboratory of South, National Institute for Nuclear Physics(LNS-INFN)(南部国家实验室,核物理研究所)
Novel Radiomic Feature for Survival Prediction of Lung Cancer Patients using Low-Dose CBCT Images
Indian Institute of Technology Kharagpur(印度理工学院卡拉格普尔分校);Tata Medical Center(塔塔医学中心);Arden Cancer Centre(雅顿癌症中心);University Hospitals Coventry and Warwickshire(考文垂与沃里克郡大学医院)
Consensus in the Parliament of AI: Harmonized Multi-Region CT-Radiomics and Foundation-Model Signatures for Multicentre NSCLC Risk Stratification
Maastricht University(马斯特里赫特大学);Quibim SL;La Fe Health Research Institute(拉费健康研究所);La Fe University and Polytechnic Hospital(拉费大学与理工医院);Sapienza University of Rome(罗马第一大学);Université d'Angers(昂热大学);CHU Angers(昂热大学医院);Nîmes University Hospital(尼姆大学医院);Saint Joseph Hospital(圣约瑟夫医院)
Imbalance-Aware Self-Supervised Learning for 3D Radiomic Representations
Technical University of Munich(慕尼黑工业大学);University of Zurich(苏黎世大学);Southern University of Science and Technology(南方科技大学);ETH Zurich(苏黎世联邦理工学院);Macau University of Science and Technology(澳门科技大学);Klinikum rechts der Isar(伊萨尔河右岸医院)
Multimodal Doctor-in-the-Loop: A Clinically-Guided Explainable Framework for Predicting Pathological Response in Non-Small Cell Lung Cancer
Research Unit of Computer Systems and Bioinformatics, Department of Engineering(计算机系统与生物信息学研究单位,工程系);Research Unit of Radiation Oncology, Department of Medicine and Surgery(放射肿瘤学研究单位,医学与外科系);Research Unit of Anatomical Pathology, Department of Medicine and Surgery(病理学研究单位,医学与外科系)
Enrichment of the NLST and NSCLC-Radiomics computed tomography collections with AI-derived annotations
Brigham and Women's Hospital(布莱根妇女医院);Mass General Brigham(麻省总医院布里格姆医疗系统);Harvard Medical School(哈佛医学院);PixelMed Publishing(PixelMed出版公司);Massachusetts General Hospital(麻省总医院);Dana-Farber Cancer Institute(达纳-法伯癌症研究所);Maastricht University(马斯特里赫特大学)
Click, Predict, Trust: Clinician-Guided and Clinician-Evaluated AI Segmentation for Lung Cancer CT-Based Prognosis within the Knowledge-to-Action Framework
BC Cancer Research Institute(BC癌症研究所);University of British Columbia(不列颠哥伦比亚大学);Technological Virtual Collaboration (TECVICO Corp.)(技术虚拟协作公司(TECVICO Corp.));Amirkabir University of Technology(阿米尔卡比尔理工大学);Islamic Azad University(伊斯兰阿扎德大学);Motamed Cancer Institute(莫塔梅德癌症研究所);ACECR(伊朗学术中心教育、文化与研究组织);University of Isfahan(伊斯法罕大学);Hamadan University of Medical Sciences(哈马丹医科大学);Rajaie Cardiovascular Medical and Research Center(拉贾伊心血管医学与研究中心);Iran University of Medical Science(伊朗医科大学);Paracelsus Medical University(帕拉塞尔苏斯医科大学);BC Cancer(BC癌症中心)
Spatio-Temporal Hybrid Fusion of CAE and SWIn Transformers for Lung Cancer Malignancy Prediction
Concordia University(康考迪亚大学);Concordia Institute for Information Systems Engineering(康考迪亚信息系统工程研究所);Sunnybrook Health Sciences Centre(桑尼布鲁克健康科学中心);University of Toronto(多伦多大学)
MIXCAPS: A Capsule Network-based Mixture of Experts for Lung Nodule Malignancy Prediction
Concordia Institute for Information Systems Engineering, Concordia University(康考迪亚大学信息系统工程研究所);Sunnybrook Health Sciences Centre, University of Toronto(多伦多大学桑尼布鲁克健康科学中心);McGill University Health Center- Research Institute(麦吉尔大学健康中心研究所);Babak Imaging Center(巴布克影像中心);Department of Electrical and Computer Engineering, University of Toronto(多伦多大学电气与计算机工程系)
Unraveling Radiomics Complexity: Strategies for Optimal Simplicity in Predictive Modeling
Université de Sherbrooke(谢布鲁克大学);OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf(德累斯顿工业大学卡尔·古斯塔夫·卡鲁斯医学院及大学医院OncoRay肿瘤放射研究国家中心,德累斯顿-罗森多夫亥姆霍兹研究中心);Cedars-Sinai Medical Center(西达赛奈医疗中心);University of California San Francisco(加利福尼亚大学旧金山分校);Stanford University(斯坦福大学)
Imaging-Based Mortality Prediction in Patients with Systemic Sclerosis
Department of Computer Science, Northwestern University, Evanston, IL 60208, USA Division of Pulmonary;Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA Machine \& Hybrid Intelligence Lab, Department of Radiology, Northwestern University, Chicago, IL 60611, USA Division of Rheumatology, Northwestern University, Chicago, IL 60611, USA Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA Section of Rheumatology, Allergy \& Immunology, Yale University, New Haven, CT 06520, USA Department of Electrical;Computer Engineering, Northwestern University, Evanston, IL 60208, USA
Novel Radiomic Measurements of Tumor- Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Case Western Reserve University(凯斯西储大学);Picture Health(Picture Health公司);Stony Brook University(石溪大学);University Hospitals Cleveland Medical Center(克利夫兰大学医院医学中心);Yale School of Medicine(耶鲁医学院);The Cleveland Clinic Foundation (CCF)(克利夫兰诊所基金会(CCF));New York University (NYU) Langone Medical Center(纽约大学(NYU)朗格尼医学中心);Louis Stokes Cleveland Veterans Medical Center(路易斯·斯托克斯克利夫兰退伍军人医学中心)
目的:肿瘤相关血管系统与健康血管的不同之处在于其混乱的结构和扭曲性,这会促进治疗抵抗。这些属性的可测量差异可能有助于根据全身治疗(例如化疗)的可能获益对患者进行分层。在这项工作中,我们提出了一类新的放射性生物标志物,称为定量肿瘤相关血管系统(QuanTAV)特征,并证明了它们预测多种癌症,成像方式和治疗方案的反应和生存的能力。实验设计:我们对558名患者的常规治疗前放射学(CT或对比增强MRI)进行了肿瘤血管分割并计算了扭曲和组织的数学测量值,这些患者接受了乳腺癌(n=371)或非小细胞肺癌(NSCLC,n=187)的四种一线化疗治疗干预策略之一。结果如下:在4种基于化疗的治疗策略中,QuanTAV测量的分类器显著(p<0.05)预测了单独保持测试队列的反应(AUC=0.63-0.71),并且当添加到单独的重要临床变量模型中时,AUC增加了0.06-0.12。QuanTAV风险评分是乳腺癌化疗(p=0.002,HR=1.25,95% CI 1.08-1.44,C指数= 0.66)和NSCLC放化疗(p=0.039,HR=1.28,95% CI 1.01-1.62,C指数=0.66)治疗队列中无复发生存期的预后指标。在所有治疗组中,包括接受化疗的NSCLC患者(p=0.034,HR=2.29,95% CI 1.07-4.94,C指数=0.62),分类QuanTAV风险组具有独立预后。…
Enhanced Lung Cancer Survival Prediction using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets
BC Cancer Research Institute(不列颠哥伦比亚省癌症研究所);University of British Columbia(不列颠哥伦比亚大学);Technological Virtual Collaboration (TECVICO Corp.)(技术虚拟协作(TECVICO公司));Hamadan University of Medical Sciences(哈马丹医科大学);Rajaie Cardiovascular Medical and Research Center(拉贾伊心血管医学研究中心);Iran University of Medical Science(伊朗医科大学);BC Cancer(不列颠哥伦比亚省癌症中心)
Integrative Analysis for COVID-19 Patient Outcome Prediction
Rensselaer Polytechnic Institute(伦斯勒理工学院);Massachusetts General Hospital(麻省总医院);Harvard Medical School(哈佛医学院);Firoozgar Hospital(菲鲁兹加尔医院);Iran University of Medical Sciences(伊朗医科大学);Azienda Ospedaliero-universitaria di Cagliari(卡利亚里大学医院)